2019
DOI: 10.12950/rsm.190423
|View full text |Cite
|
Sign up to set email alerts
|

Dispersal rates of astatine-211 from aqueous solutions and chloroform

Abstract: The dispersal rates of 211 At, which is a promising nuclide for targeted alpha therapy, from aqueous solutions and chloroform were studied to provide experimental evidence for the reasonable evaluation of its airborne concentration in a radiation-controlled area. Using a collection unit for dispersed 211 At during ventilation, radioactivity of the trapped 211 At was quantified. The dispersal rates of 211 At in chloroform as well as acidic, neutral, and alkaline solutions, in addition to a neutral solution con… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
3
0

Year Published

2020
2020
2022
2022

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 7 publications
0
3
0
Order By: Relevance
“…211 At was produced in the 209 Bi(a, 2n) 211 At reaction using the K140 AVF cyclotron at Research Center of Nuclear Physics, Osaka University. 211 At was separated from the 209 Bi target by dry distillation according to the literature procedures 11,12) . The aqueous solution containing 211 At was obtained by dissolution of 211 At in distilled water.…”
Section: -1 Materialsmentioning
confidence: 99%
“…211 At was produced in the 209 Bi(a, 2n) 211 At reaction using the K140 AVF cyclotron at Research Center of Nuclear Physics, Osaka University. 211 At was separated from the 209 Bi target by dry distillation according to the literature procedures 11,12) . The aqueous solution containing 211 At was obtained by dissolution of 211 At in distilled water.…”
Section: -1 Materialsmentioning
confidence: 99%
“…Evaluating the vaporization and the movement of 211 At in the air is challenging because of the low detection capability for α-particle-emitter especially in a large space as a lab room. Some literature referred to the radiation safety of 211 At in production, but we could not find any literature referring to this phenomenon as a radiation safety issue [ 4 , 5 ].…”
Section: Introductionmentioning
confidence: 99%
“…In the production of [ 211 At]NaAt solutions for the current clinical trial, we add ascorbic acid and adjust the pH to increase the Atcomponent, which then stabilizes the behavior of 211 At [3]. As a result, the volatility of 211 At is dramatically decreased, and 211 At can be safely handled by healthcare professionals [4,5]. Nevertheless, as safe handling is the most important aspect of clinical application, we need to pay special attention to contamination.…”
mentioning
confidence: 99%